Adjunctive Cannabidiol for Recovery From Opioid Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Adjunctive Cannabidiol for Recovery From Opioid Study — Stella

Home/Opioid Use Disorder (OUD)/

View on ClinicalTrials.gov

Recruiting

Back to Opioid Use Disorder (OUD) trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(2 sites)

United States

Icahn School of Medicine at Mount Sinai, New York, New York

CODA Treatment Recovery, Portland, Oregon

Key details

Phase

Large-scale testing

Sponsor

Icahn School of Medicine at Mount Sinai

Collaborators

National Institute on Drug Abuse (NIDA), International Center for Health Outcomes and Innovation Research

Enrollment target

~450 participants

Started

June 2025

Primary completion

July 2027

Age range

18 Years – 65 Years

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.